서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 61 to 120 of 245

Issue DateTitle / Author(s) / CitationFileAltmetrics
2007-11
Preliminary results of pre-radiation neck dissection in head and neck cancer patients undergoing organ preservation treatment
link
2007-11
Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer
link
2007-12
Chemotherapy use and associated factors among cancer patients near the end of life.
DOI
2008-01
Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma
link
2008-02
Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer
DOI
2008-05
Aggressiveness of cancer-care near the end-of-life in Korea

Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Mi Ra; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Heo, Dae Seog

Japanese Journal of Clinical Oncology, Vol.38 No.5, pp.381-386

DOI
2008-05
A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker
DOI
2008-05
Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines
link
2008-05
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker
view fileDOI
2008-06
Gemcitabine and Vinorelbine Combination Chemotherapy in Anthracycline- and Taxane-pretreated Advanced Breast Cancer
2008-06
ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
DOI
2008-06
Upfront chemotherapy and involved-field radiotherapy results in more relapses than extended radiotherapy for intracranial germinomas: modification in radiotherapy volume might be needed
link
2008-07
Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment
DOI
2008-12
Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients
DOI
2008-12
Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
view fileDOI
2009-03
The role of PET/CT in detection of gastric cancer recurrence
view fileDOI
2009-05
Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: A retrospective analysis
view fileDOI
2009-05
Presence of Membrane-Bound TGF-β1 and Its Regulation by IL-2-Activated Immune Cell-Derived IFN-γ in Head and Neck Squamous Cell Carcinoma Cell Lines

Ahn, Yong-Oon; Lee, June-Chul; Sung, Myung-Whun; Heo, Dae Seog

JOURNAL OF IMMUNOLOGY; Vol.182 10; 6114-6120

DOI
2009-06
Absence of STAT1 disturbs the anticancer effect induced by STAT3 inhibition in head and neck carcinoma cell lines

Shim, Seon-Hui; Sung, Myung-Whun; Park, Seok-Woo; Heo, Dae Seog

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE; Vol.23 6; 805-810

DOI
2009-07
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI
DOI
2009-07
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy
DOI
2009-08
Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin
DOI
2009-08
Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma
DOI
2009-08
Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer
DOI
2009-09
INTENSITY-MODULATED RADIATION THERAPY WITH SIMULTANEOUS INTEGRATED BOOST TECHNIQUE FOLLOWING NEOADJUVANT CHEMOTHERAPY FOR LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA

Kim, Kyubo; Wu, Hong-Gyun; Kim, Hak Jae; Sung, Myung-Whun; Lee, Se-Hoon; Kim, Hee Jung; Park, Charn Il; Heo, Dae Seog; Kim, Kwang Hyun

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK; Vol.31 9; 1121-1128

DOI
2009-09
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement
DOI
2009-12
Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy
view fileDOI
2010-02
Conditionally replicating adenovirus improves gene replication efficiency and anticancer effect of E1-deleted adenovirus carrying TRAIL in head and neck squamous cell carcinoma
DOI
2010-03
Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer
DOI
2010-04
Dexamethasone treatment inhibits VEGF production via suppression of STAT3 in a head and neck cancer cell line
DOI
2010-05
First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors
view fileDOI
2010-06
Impact of caregivers' unmet needs for supportive care on quality of terminal cancer care delivered and caregiver's workforce performance
DOI
2010-06
Impact of caregivers' unmet needs for supportive care on quality of terminal cancer care delivered and caregiver's workforce performance
DOI
2010-06
The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer
DOI
2010-08
Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy
view fileDOI
2010-12
A combination treatment with SAHA and ad-p63/p73 shows an enhanced anticancer effect in HNSCC
DOI
2011-01
A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinonna harboring EGFR mutations
DOI
2011-02
Increasing Nodal Ratio is a Poor Prognostic Factor for Survival in Stage III-IV (M0) Gastric Cancer Patients Who Received Curative Surgery Followed by Adjuvant Chemotherapy: A Retrospective Study
DOI
2011-03
Role of Postoperative Radiotherapy for Patients with Pathological Stage III Non-Small-Cell Lung Cancer after Curative Resection
DOI
2011-03
Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: The 10-year experience of a single center
DOI
2011-03
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
view fileDOI
2011-04
EGFR Gene Copy Number Gain is Related to High Tumor SUV and Frequent Relapse after Adjuvant Chemotherapy in Resected Lung Adenocarcinoma
DOI
2011-05
Clinicopathologic Characteristics and Outcomes of Patients with Anaplastic Lymphoma Kinase-Positive Advanced Pulmonary Adenocarcinoma Suggestion for an Effective Screening Strategy for These Tumors
DOI
2011-07
Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial
DOI
2011-07
MicroRNA-146a Downregulates NF kappa B Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell Lymphoma

Paik, Jin Ho; Jang, Ji-Young; Jeon, Yoon Kyung; Kim, Wook Youn; Kim, Tae Min; Heo, Dae Seog; Kim, Chul-Woo

CLINICAL CANCER RESEARCH, Vol.17 No.14, pp.4761-4771

DOI
2011-08
Clinical dissection of multicentric Castleman disease
DOI
2011-09
Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy
DOI
2011-09
VEGF Expression is Related to Good Response and Long Progression-free Survival in Gastrointestinal Stromal Tumor Patients Treated With Sunitinib
DOI
2011-09
Anaplastic Lymphoma Kinase Translocation A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer
DOI
2011-11
Clinical significance of tumor-infiltrating FOXP3+T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
view fileDOI
2012-01
Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment
DOI
2012-02
Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer
view fileDOI
2012-02
Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy
DOI
2012-06
Remarkable Tumor Response to Crizotinib in a 14-Year-Old Girl With ALK-Positive Non-Small-Cell Lung Cancer

Kim, Su-Jung; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog; Bang, Yung-Jue

Journal of Clinical Oncology, Vol.30 No.16, pp.E147-E150

DOI
2012-07
Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer
DOI
2012-08
Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients
DOI
2012-08
EGFR mutations as a predictive marker of cytotoxic chemotherapy
DOI
2012-08
Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation
DOI
2012-09
Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis
DOI
2012-11
The Lack of CD34 Expression in Gastrointestinal Stromal Tumors is Related to Cystic Degeneration Following Imatinib Use
DOI
1 2 3 4 5